Healthcare Update Q4 2023
It was a challenging Q3 with healthcare indices trading down in line with the market, as macro-economic uncertainty persists. While the XBI nearly dropped to a new 6-year low, the only green spot was European big pharma which ended on a positive, largely driven by Novo. In biotech-land, 22% of comp
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.